Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
1,953,627
-
Share change
-
+815,867
-
Total reported value
-
$276,365,000
-
Put/Call ratio
-
274%
-
Price per share
-
$141.42
-
Number of holders
-
92
-
Value change
-
+$114,944,238
-
Number of buys
-
42
-
Number of sells
-
38
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q4 2016
As of 31 Dec 2016,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,953,627 shares.
The largest 10 holders included
Clal Insurance Enterprises Holdings Ltd, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, Pinnacle Advisory Group, Inc., ARS Wealth Advisors, LLC, Bogart Wealth, LLC, BROWN ADVISORY INC, ROYAL BANK OF CANADA, SPINNAKER TRUST, and GOLDMAN SACHS GROUP INC.
This page lists
92
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.